And by targeting GPX4 can induce ferroptosis in lung adenocarcinoma cells and reverse their resistance to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) [66]. This evidence concerns the gene GPX4 and lung adenocarcinoma.